Traws Pharma, Inc. (TRAW)
NASDAQ: TRAW · IEX Real-Time Price · USD
0.432
-0.018 (-4.09%)
At close: Jul 19, 2024, 4:00 PM
0.440
+0.008 (1.95%)
Pre-market: Jul 22, 2024, 8:38 AM EDT
Traws Pharma Employees
As of December 31, 2023, Traws Pharma had 18 total employees, including 17 full-time and 1 part-time employees. The number of employees increased by 1 or 5.88% compared to the previous year.
Employees
18
Change (1Y)
1
Growth (1Y)
5.88%
Revenue / Employee
$12,556
Profits / Employee
-$1,008,667
Market Cap
10.92M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Mustang Bio | 80 |
Senti Biosciences | 48 |
Calidi Biotherapeutics | 41 |
Vaccinex | 40 |
Dominari Holdings | 28 |
Moleculin Biotech | 18 |
BioRestorative Therapies | 11 |
Cardio Diagnostics Holdings | 9 |
TRAW News
- 3 months ago - Traws Pharma Announces New Employee Inducement Grants - GlobeNewsWire
- 4 months ago - Onconova Therapeutics' Rigosertib Poster Selected for AACR 2024 - GlobeNewsWire
- 8 months ago - Onconova Therapeutics' Preclinical Narazaciclib Data at SABCS Highlights Differentiated Anti-Tumor Activity v. Other CDK4/6i's - GlobeNewsWire
- 8 months ago - Onconova Therapeutics to Present at NobleCon19, Noble Capital Markets' Nineteenth Annual Emerging Growth Equity Conference - GlobeNewsWire
- 8 months ago - Onconova Therapeutics Reports Corporate Update and Announces Third Quarter 2023 Financial Results - GlobeNewsWire
- 9 months ago - Onconova Therapeutics to Provide Corporate Update and Announce Third Quarter 2023 Financial Results on November 14, 2023 - GlobeNewsWire
- 9 months ago - Onconova Therapeutics' ASH Poster To Focus on Narazaciclib in MCL - GlobeNewsWire
- 9 months ago - Onconova Expands Leadership Team with Two Key Appointments - GlobeNewsWire